EP2170064A4 - Antagonistes 6,5-pyrrolopipéridine des récepteurs de tachykinine - Google Patents

Antagonistes 6,5-pyrrolopipéridine des récepteurs de tachykinine

Info

Publication number
EP2170064A4
EP2170064A4 EP08771300A EP08771300A EP2170064A4 EP 2170064 A4 EP2170064 A4 EP 2170064A4 EP 08771300 A EP08771300 A EP 08771300A EP 08771300 A EP08771300 A EP 08771300A EP 2170064 A4 EP2170064 A4 EP 2170064A4
Authority
EP
European Patent Office
Prior art keywords
pyrrolopiperidine
antagonists
tachykinin receptors
tachykinin
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08771300A
Other languages
German (de)
English (en)
Other versions
EP2170064A1 (fr
Inventor
Jianming Bao
Robert J Devita
Huagang Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme Ltd
Publication of EP2170064A1 publication Critical patent/EP2170064A1/fr
Publication of EP2170064A4 publication Critical patent/EP2170064A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP08771300A 2007-06-22 2008-06-18 Antagonistes 6,5-pyrrolopipéridine des récepteurs de tachykinine Withdrawn EP2170064A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93686407P 2007-06-22 2007-06-22
PCT/US2008/067270 WO2009002770A1 (fr) 2007-06-22 2008-06-18 Antagonistes 6,5-pyrrolopipéridine des récepteurs de tachykinine

Publications (2)

Publication Number Publication Date
EP2170064A1 EP2170064A1 (fr) 2010-04-07
EP2170064A4 true EP2170064A4 (fr) 2010-08-04

Family

ID=40185984

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08771300A Withdrawn EP2170064A4 (fr) 2007-06-22 2008-06-18 Antagonistes 6,5-pyrrolopipéridine des récepteurs de tachykinine

Country Status (5)

Country Link
EP (1) EP2170064A4 (fr)
JP (1) JP2010530874A (fr)
AU (1) AU2008268667A1 (fr)
CA (1) CA2690737A1 (fr)
WO (1) WO2009002770A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101074202B1 (ko) * 2007-01-18 2011-10-14 에스케이종합화학 주식회사 에틸렌 사량체화 촉매계 및 이를 이용한 1-옥텐의 제조방법
HRP20171739T1 (hr) * 2009-11-20 2018-03-09 Tonix Pharma Holdings Limited Postupci i kompozicije za liječenje simptoma povezanih s posttraumatskim stresnim poremećajem korištenjem ciklobenzaprina
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
WO2013004766A1 (fr) 2011-07-04 2013-01-10 Ferrari Giulio Antagonistes des récepteurs nk-1 pour traiter une néovascularisation cornéenne
SG11201404880UA (en) 2012-02-22 2014-09-26 Leo Pharma As Novel neurokinin 1 receptor antagonist compounds
AR092211A1 (es) * 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung Derivados de hidropirrolopirrol
JP6310542B2 (ja) 2013-03-15 2018-04-11 トニックス ファーマシューティカルズ， インコーポレイテッド シクロベンザプリン塩酸塩およびアミトリプチリン塩酸塩の共融製剤
CN105579456A (zh) * 2013-08-20 2016-05-11 利奥制药有限公司 新型神经激肽1受体拮抗剂化合物ii
WO2015024203A1 (fr) 2013-08-20 2015-02-26 Leo Pharma A/S Nouveaux composés ii antagonistes du récepteur de la neurokinine 1
SG11201701995PA (en) 2014-09-18 2017-04-27 Tonix Pharma Holdings Ltd Eutectic formulations of cyclobenzaprine hydrochloride
US11826321B2 (en) 2017-12-11 2023-11-28 Tonix Pharma Holdings Limited Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
CN111918647A (zh) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 用于治疗眼痛的nk-1拮抗剂
WO2021180885A1 (fr) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Traitement d'une déficience en cellules souches

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110996A1 (fr) * 2003-06-19 2004-12-23 Pfizer Products Inc. Antagoniste de nk1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
JP2008523147A (ja) * 2004-12-14 2008-07-03 メルク エンド カムパニー インコーポレーテッド オクタヒドロピラノ［３，４−ｃ］ピロールタキキニン受容体拮抗薬

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110996A1 (fr) * 2003-06-19 2004-12-23 Pfizer Products Inc. Antagoniste de nk1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009002770A1 *

Also Published As

Publication number Publication date
WO2009002770A1 (fr) 2008-12-31
CA2690737A1 (fr) 2008-12-31
JP2010530874A (ja) 2010-09-16
AU2008268667A1 (en) 2008-12-31
EP2170064A1 (fr) 2010-04-07

Similar Documents

Publication Publication Date Title
EP2170064A4 (fr) Antagonistes 6,5-pyrrolopipéridine des récepteurs de tachykinine
FR22C1020I2 (fr) Antagonistes de c5ar
BRPI0910592A2 (pt) antagonistas de receptor 2 de somatostatina
EP2348846A4 (fr) Antagonistes des récepteurs de l'orexine de type azépane disubstitué
EP2150115A4 (fr) Antagonistes du récepteur de la cyclopropylpyrrolidine orexine
HRP20151108T1 (xx) Antagonisti nogo-receptora
ATE505467T1 (de) 2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten
DK2089382T3 (da) Substituerede diazepan-forbindelser som orexin-receptor-antagonister
EP2004654A4 (fr) Antagonistes de la kinase
EP2214676A4 (fr) Antagonistes des récepteurs de l'orexine, de type diazépan substitué
EP2350304A4 (fr) Antagonistes du récepteur 3 de type toll
EP2131654A4 (fr) Carboxamides de bipyridine, antagonistes du récepteur de l'orexine
ATE509928T1 (de) 8-azabicycloä3.2.1üoktan-verbindungen als mu- opioid-rezeptorantagonisten
BRPI0717937A2 (pt) Compostos de pirazona como antagonistas do receptor mineralocorticóide
EP2349270A4 (fr) Antagonistes de récepteur d orexine de morpholine 2,5-disubstituée
EP2350061A4 (fr) Antagonistes de récepteur de l'orexine de type pipéridine 2,3-disubstituée
BR112012003701A2 (pt) "novos antagonistas de quinolina-hepcidina"
EP2049110A4 (fr) Diazépans pontés antagonistes du récepteur de l'oréxine
ATE481405T1 (de) Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors
BRPI0718494A2 (pt) Derivado de fenilsulfamoil benzamida como antagonistas de bradicinina
DK2009992T3 (da) Il-8 receptor-antagonister
EP2254413A4 (fr) Antagonistes de récepteurs de cgrp de type imidazobenzazépine
DK2121630T3 (da) Hurtigt dissocierende dopamin-2-receptor-antagonister
DE602005004011D1 (de) Hydroisoindolin-tachykininrezeptorantagonisten
BRPI0720078A2 (pt) 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100707

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/24 20060101ALI20100701BHEP

Ipc: A61P 25/22 20060101ALI20100701BHEP

Ipc: A61P 25/06 20060101ALI20100701BHEP

Ipc: A61P 13/00 20060101ALI20100701BHEP

Ipc: A61K 31/437 20060101ALI20100701BHEP

Ipc: C07D 471/04 20060101AFI20100701BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110207